Very low levels of vitamin D in systemic sclerosis patients

Clinical Rheumatology

Volumn 29, Issue 12, 2010, Pages 1419-1425

  Caramaschi, Paola ^a   Dalla Gassa, Alessandra ^a   Ruzzenente, Orazio ^a   Volpe, Alessandro ^b   Ravagnani, Viviana ^a   Tinazzi, Ilaria ^a   Barausse, Giovanni ^a   Bambara, Lisa M ^a   Biasi, Domenico ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Ospedale di Negrar   (Italy)

Author keywords

Systemic sclerosis; Vitamin D

Indexed keywords

C REACTIVE PROTEIN; VITAMIN D;

ADULT; ARTICLE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LUNG ARTERY PRESSURE; LUNG CAPACITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGED; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78649326513     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1478-3     Document Type: Article

References (26)

1. S Nagpal S Na R Rathnachalam 2005 Noncalcemic actions of vitamin D receptor ligands Endocr Rev 26 662 687 1:CAS:528:DC%2BD2MXps1Kit7s%3D 10.1210/er.2004-0002 15798098 (Pubitemid 41127276)
2. P Szodoray B Nakken J Gaal, et al. 2008 The complex role of vitamin D in autoimmune diseases Scand J Immunol 68 261 269 1:CAS:528:DC%2BD1cXhtFajtrnN 10.1111/j.1365-3083.2008.02127.x 18510590
3. PW Wu EY Rhew AR Dyer, et al. 2009 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus Arthritis Rheum 61 1387 1395 1:CAS:528:DC%2BD1MXhtlKqt7nM 10.1002/art.24785 19790113
4. TB Wright J Shults LMB Zemel BJM BS 2009 Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus J Pediatr 155 260 265 1:CAS:528:DC%2BD1MXos12quro%3D 10.1016/j.jpeds.2009.02.033 19446841
5. CM Veldman MT Cantorna DE Luca HF 2000 Expression of 1, 25-dihydroxyvitamin D3 receptor in the immune system Arch Biochem Biophys 374 334 338 1:CAS:528:DC%2BD3cXpsVagtA%3D%3D 10.1006/abbi.1999.1605 10666315 (Pubitemid 30120270)
6. JW Morgan N Kouttab D Ford AL Maizel 2000 Vitamin D-mediated gene regulation in phenotypically defined B cells sub-populations Endocrinology 141 3225 3234 1:CAS:528:DC%2BD3cXmtVersLc%3D 10.1210/en.141.9.3225 10965893 (Pubitemid 32269010)
7. JM Lemire DC Archer 1991 1, 25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis J Clin Invest 87 1103 1107 1:CAS:528:DyaK3MXhslyqtr4%3D 10.1172/JCI115072 1705564
8. Fernandes de Abreu DA D Eyles F Feron 2009 Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases Psyconeuroendocrinology 34 suppl 1 S265 S277 10.1016/j.psyneuen.2009. 05.023
9. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee 1980 Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum 23 581 590 10.1002/art.1780230510
10. EC LeRoy CM Black R Fleischmajer, et al. 1988 Scleroderma (systemic sclerosis): classification, subsets and pathogenesis J Rheumatol 15 202 205 1:STN:280:DyaL1c3gtVWnsg%3D%3D 3361530
11. A Akesson G Fiori T Krieg FHJ van den Hoogen JR Seibold 2003 Assessment of skin, joint, tendon and muscle involvement Clin Exp Rheumatol 21 suppl 29 S5 S8 1:STN:280:DC%2BD3szlslaisw%3D%3D 12889214
12. G Valentini A Della Rossa S Bombardieri, et al. 2001 European multicentre study to define disease activity for systemic sclerosis. Identification of disease activity variables and development of preliminary activity indexes Ann Rheum Dis 60 592 8 1:STN:280:DC%2BD3M3lt1WqsQ%3D%3D 10.1136/ard.60.6.592 11350848 (Pubitemid 32493986)
13. M Cutolo A Sulli C Pizzorni S Accardo 2000 Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis J Rheumatol 27 155 160 1:STN:280:DC%2BD3c7ht1Gmug%3D%3D 10648032
14. TA Medsger Jr S Bombardieri L Czjriak R Scorza A Della Rossa W Bencivelli 2003 Assessment of disease severity and prognosis Clin Exp Rheumatol 21 suppl 29 S42 6 12889222
15. A Vacca C Cormier M Piras A Mathieu A Kahan Y Allanore 2009 Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with Systemic Sclerosis J Rheumatol 36 1924 1929 1:CAS:528:DC%2BD1MXhtF2jurjN 10.3899/jrheum.081287 19648299
16. A Dovio V Data R Carignola, et al. 2008 Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis J Rheumatol 35 2206 2213 1:CAS:528:DC%2BD1cXhsVKmtrnP 10.3899/jrheum.080192 18843778
17. Y Braun-Moscovici DE Furst D Markovits, et al. 2008 Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosis J Rheumatol 35 2201 2205 1:CAS:528:DC%2BD1cXhsVKmtrnO 10.3899/jrheum.071171 18843781
18. H Orbach G Zandman-Goddard H Amital, et al. 2007 Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases Ann NY Acad Sci 1109 385 400 1:CAS:528:DC%2BD2sXhtVyjsb%2FP 10.1196/annals.1398.044 17785327 (Pubitemid 47511381)
19. DL Kamen GS Cooper H Bouali SR Shaftman BW Hollis GS Gilkeson 2006 Vitamin D deficiency in systemic lupus erythematosus Autoimmun Rev 5 114 117 1:CAS:528:DC%2BD28XisFWqs7s%3D 10.1016/j.autrev.2005.05.009 16431339 (Pubitemid 43129539)
20. E Zold P Szodoray J Gaal, et al. 2008 Vitamin D deficiency in undifferentiated connective tissue disease Arthritis Res Ther 10 R123 10.1186/ar2533 18928561
21. G Isaia R Giorgino GB Rini M Bevilacqua D Maugeri S Adami 2003 Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors Osteoporos Int 14 577 582 1:CAS:528:DC%2BD3sXls1ynsLo%3D 10.1007/s00198-003-1390-7 12856111 (Pubitemid 36975557)
22. C Bryan Y Howard P Brennan Cm Black A Silman 1996 Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population Br J Rheumatol 35 1122 6 1:STN:280:DyaK2s7gsVWgsQ%3D%3D 10.1093/rheumatology/35.11.1122 8948299
23. M Matucci-Cerinic S D'Angelo CP Denton P Vlachoyannopoulos R Silver 2003 Assessment of lung involvement Clin Exp Rheumatol 21 suppl 29 S19 S23 1:STN:280:DC%2BD3szlslaitg%3D%3D 12889217
24. JN Artaza KC Norris 2009 Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells J Endocrinol 200 207 221 1:CAS:528:DC%2BD1MXjvVOguro%3D 10.1677/JOE-08-0241 19036760
25. AM Ramirez C Wongtrakool T Welch A Steinmeyer U Zugel J Roman 2010 Vitamin D inhibition of pro-fibrotic effects on transforming growth factor β1 in lung fibroblasts and epithelial cells J Steroid Biochem Mol Biol 118 142 150 1:CAS:528:DC%2BC3cXhtVejsbo%3D 10.1016/j.jsbmb.2009.11.004 19931390
26. BC Willis JM Liebler K Luby-Phelps, et al. 2005 Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis Am J Pathol 166 1321 1332 1:CAS:528:DC%2BD2MXksFGmtL8%3D 15855634